{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,2]],"date-time":"2025-10-02T00:47:22Z","timestamp":1759366042025,"version":"build-2065373602"},"reference-count":30,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.es","elsevier.es","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Gastroenterolog\u00eda y Hepatolog\u00eda"],"published-print":{"date-parts":[[2022,4]]},"DOI":"10.1016\/j.gastrohep.2021.09.003","type":"journal-article","created":{"date-parts":[[2021,9,17]],"date-time":"2021-09-17T10:52:32Z","timestamp":1631875952000},"page":"265-273","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Influencia de los trastornos psiqui\u00e1tricos y la terapia de sustituci\u00f3n con opi\u00e1ceos en el tratamiento del virus de la hepatitis c con antivirales de acci\u00f3n directa en usuarios de drogas por v\u00eda parenteral"],"prefix":"10.1016","volume":"45","author":[{"given":"Jos\u00e9 Carlos","family":"Fern\u00e1ndez de Ca\u00f1ete Camacho","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Antonio","family":"Mancebo Mart\u00ednez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mar\u00eda Adela","family":"Garc\u00eda Mena","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jos\u00e9 Mar\u00eda","family":"Moreno Planas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.gastrohep.2021.09.003_bib0155","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1016\/j.jhep.2018.03.026","article-title":"EASL Recommendations on Treatment of Hepatitis C 2018","volume":"69","author":"Pawlotsky","year":"2018","journal-title":"J Hepatol"},{"issue":"Suppl 1","key":"10.1016\/j.gastrohep.2021.09.003_bib0160","doi-asserted-by":"crossref","first-page":"S5","DOI":"10.1111\/jvh.12247","article-title":"Historical epidemiology of hepatitis C virus (HCV) in selected countries","volume":"21","author":"Bruggmann","year":"2014","journal-title":"J Viral Hepat"},{"key":"10.1016\/j.gastrohep.2021.09.003_bib0165","doi-asserted-by":"crossref","first-page":"625","DOI":"10.7326\/M16-0816","article-title":"Elbasvir-grazoprevir to treat hepatitis C virus infection in persons receiving opioid agonist therapy a randomized trial","volume":"165","author":"Dore","year":"2016","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.gastrohep.2021.09.003_bib0170","doi-asserted-by":"crossref","first-page":"ofy001","DOI":"10.1093\/ofid\/ofy001","article-title":"Sofosbuvir-based direct-acting antiviral therapies for HCV in people receiving opioid substitution therapy: An analysis of phase 3 studies","volume":"5","author":"Grebely","year":"2018","journal-title":"Open Forum Infect Dis"},{"key":"10.1016\/j.gastrohep.2021.09.003_bib0175","first-page":"221","volume":"13","year":"2016","journal-title":"Global health sector strategy on viral hepatitis 2016-2021 Glob Hepat Program Dep HIV\/AIDS"},{"issue":"Suppl 2","key":"10.1016\/j.gastrohep.2021.09.003_bib0180","doi-asserted-by":"crossref","first-page":"S80","DOI":"10.1093\/cid\/cit306","article-title":"Treatment of hepatitis c virus infection among people who are actively injecting drugs: A systematic review and meta-analysis","volume":"57","author":"Aspinall","year":"2013","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.gastrohep.2021.09.003_bib0185","doi-asserted-by":"crossref","first-page":"1385","DOI":"10.1016\/S1473-3099(16)30325-5","article-title":"Estimating the burden of disease attributable to injecting drug use as a risk factor for HIV, hepatitis C, and hepatitis B: Findings from the Global Burden of Disease Study 2013","volume":"16","author":"Degenhardt","year":"2016","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.gastrohep.2021.09.003_bib0190","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1080\/23744235.2017.1334263","article-title":"Prevalence of hepatitis C and pre-testing awareness of hepatitis C status in 1500 consecutive PWID participants at the Stockholm needle exchange program","volume":"49","author":"K\u00e5berg","year":"2017","journal-title":"Infect Dis (Auckl)"},{"key":"10.1016\/j.gastrohep.2021.09.003_bib0195","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1053\/gast.2002.34750","article-title":"Psychiatric disorders among veterans with hepatitis C infection","volume":"123","author":"ElSerag","year":"2002","journal-title":"Gastroenterology"},{"key":"10.1016\/j.gastrohep.2021.09.003_bib0200","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1016\/j.drugpo.2015.07.004","article-title":"Hepatitis C virus (HCV) disease progression in people who inject drugs (PWID): A systematic review and meta-analysis","volume":"26","author":"Smith","year":"2015","journal-title":"Int J Drug Policy"},{"key":"10.1016\/j.gastrohep.2021.09.003_bib0205","doi-asserted-by":"crossref","first-page":"1028","DOI":"10.1016\/j.drugpo.2015.07.005","article-title":"Recomendaciones para el manejo de la infecci\u00f3n por el virus de la hepatitis C entre usuarios de drogas por v\u00eda parenteral","author":"Grebely","year":"2015","journal-title":"Int J Drug Policy"},{"key":"10.1016\/j.gastrohep.2021.09.003_bib0210","article-title":"Analysis of Adherence to AllOral HCV Therapy in a Cohort of People who Inject Drugs (PWID)","volume":"3","author":"Shahi","year":"2017","journal-title":"J Hepat"},{"issue":"Suppl 1","key":"10.1016\/j.gastrohep.2021.09.003_bib0215","doi-asserted-by":"crossref","first-page":"S6","DOI":"10.1111\/jvh.12350","article-title":"Historical epidemiology of hepatitis C virus (HCV) in select countries - Volume 2","volume":"22","author":"Saraswat","year":"2015","journal-title":"J Viral Hepat"},{"key":"10.1016\/j.gastrohep.2021.09.003_bib0220","doi-asserted-by":"crossref","DOI":"10.20882\/adicciones.908","article-title":"Hepatitis C cr\u00f3nica y usuarios con un historial de inyecci\u00f3n de drogas en Espa\u00f1a: evaluaci\u00f3n de la poblaci\u00f3n, retos para un tratamiento efectivo","volume":"29","author":"Roncero","year":"2017","journal-title":"Adicciones"},{"key":"10.1016\/j.gastrohep.2021.09.003_bib0225","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1111\/liv.14403","article-title":"ITTREAT (Integrated Community Test - Stage - TREAT) Hepatitis C service for people who use drugs: Real-world outcomes","volume":"40","author":"O'Sullivan","year":"2020","journal-title":"Liver Int"},{"key":"10.1016\/j.gastrohep.2021.09.003_bib0230","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1016\/S2468-1253(18)30304-2","article-title":"Direct-acting antiviral treatment for hepatitis C among people who use or inject drugs: A systematic review and meta-analysis","volume":"3","author":"Hajarizadeh","year":"2018","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"10.1016\/j.gastrohep.2021.09.003_bib0235","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/j.drugpo.2017.05.032","article-title":"Delivering direct acting antiviral therapy for hepatitis C to highly marginalised and current drug injecting populations in a targeted primary health care setting","volume":"47","author":"Read","year":"2017","journal-title":"Int J Drug Policy"},{"key":"10.1016\/j.gastrohep.2021.09.003_bib0240","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1111\/jvh.12857","article-title":"Directly observed therapy of chronic hepatitis C with ledipasvir\/sofosbuvir in people who inject drugs at risk of nonadherence to direct-acting antivirals","volume":"25","author":"Sch\u00fctz","year":"2018","journal-title":"J Viral Hepat"},{"key":"10.1016\/j.gastrohep.2021.09.003_bib0245","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1016\/j.drugpo.2017.07.021","article-title":"cure rates for people who use drugs treated with direct acting antiviral therapy at an urban primary care clinic","volume":"47","author":"Norton","year":"2017","journal-title":"Int J Drug Policy"},{"key":"10.1016\/j.gastrohep.2021.09.003_bib0250","doi-asserted-by":"crossref","first-page":"1170","DOI":"10.1016\/j.jhep.2020.08.018","article-title":"EASL recommendations on treatment of hepatitis C: Final update of the series","volume":"73","author":"Pawlotsky","year":"2020","journal-title":"J Hepatol"},{"key":"10.1016\/j.gastrohep.2021.09.003_bib0255","first-page":"1477","article-title":"Hepatitis C Guidance 2019 Update: AASLD-IDSA Recommendations for Testing Managing, and Treating Hepatitis C Virus Infection","volume":"67","author":"Ghany","year":"2019","journal-title":"Hepatology"},{"key":"10.1016\/j.gastrohep.2021.09.003_bib0260","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1016\/j.gastrohep.2018.07.010","article-title":"Guidelines on treatment of hepatitis C virus infection Spanish Association for the Study of the Liver (AEEH)","volume":"41","author":"Calleja","year":"2018","journal-title":"Gastroenterol Hepatol"},{"key":"10.1016\/j.gastrohep.2021.09.003_bib0265","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1111\/j.1399-0012.1997.tb00842.x","article-title":"Vulnerability to psychologic distress and depression in patients with end-stage liver disease due to hepatitis C virus","volume":"11","author":"Singh","year":"1997","journal-title":"Clin Transplant"},{"key":"10.1016\/j.gastrohep.2021.09.003_bib0270","doi-asserted-by":"crossref","first-page":"2101","DOI":"10.1001\/archinte.160.14.2101","article-title":"Depression is a risk factor for noncompliance with medical treatment meta-analysis of the effects of anxiety and depression on patient adherence","volume":"160","author":"DiMatteo","year":"2000","journal-title":"Arch Intern Med"},{"issue":"Suppl 2","key":"10.1016\/j.gastrohep.2021.09.003_bib0275","doi-asserted-by":"crossref","first-page":"S56","DOI":"10.1093\/cid\/cit271","article-title":"Models of care for the management of hepatitis C virus among people who inject drugs: One size does not fit all","volume":"57","author":"Bruggmann","year":"2013","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.gastrohep.2021.09.003_bib0280","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1111\/add.14128","article-title":"Direct-acting antiviral treatment of chronic HCV-infected patients on opioid substitution therapy: Still a concern in clinical practice?","volume":"113","author":"Christensen","year":"2018","journal-title":"Addiction"},{"key":"10.1016\/j.gastrohep.2021.09.003_bib0285","doi-asserted-by":"crossref","DOI":"10.1093\/ofid\/ofy120","article-title":"Real-world efficacy of direct-acting antiviral therapy for HCV infection affecting people who inject drugs delivered in a multidisciplinary setting; 23;5(6):ofy120","author":"Alimohammadi","year":"2018","journal-title":"Open Forum Infect Dis"},{"key":"10.1016\/j.gastrohep.2021.09.003_bib0290","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.drugpo.2017.07.002","article-title":"Interventions to enhance testing, linkage to care and treatment uptake for hepatitis C virus infection among people who inject drugs: A systematic review","volume":"47","author":"Bajis","year":"2017","journal-title":"Int J Drug Policy"},{"key":"10.1016\/j.gastrohep.2021.09.003_bib0295","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1111\/liv.13949","article-title":"Hepatitis C elimination among people who inject drugs: Challenges and recommendations for action within a health systems framework","volume":"39","author":"Day","year":"2019","journal-title":"Liver Int"},{"key":"10.1016\/j.gastrohep.2021.09.003_bib0300","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1177\/1357633X15625136","article-title":"Management of infectious diseases in remote northwestern Ontario with telemedicine videoconference consultations","volume":"23","author":"Mashru","year":"2017","journal-title":"J Telemed Telecare"}],"container-title":["Gastroenterolog\u00eda y Hepatolog\u00eda"],"original-title":[],"language":"es","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S021057052100251X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S021057052100251X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T12:45:16Z","timestamp":1759322716000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S021057052100251X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,4]]},"references-count":30,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2022,4]]}},"alternative-id":["S021057052100251X"],"URL":"https:\/\/doi.org\/10.1016\/j.gastrohep.2021.09.003","relation":{},"ISSN":["0210-5705"],"issn-type":[{"type":"print","value":"0210-5705"}],"subject":[],"published":{"date-parts":[[2022,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Influencia de los trastornos psiqui\u00e1tricos y la terapia de sustituci\u00f3n con opi\u00e1ceos en el tratamiento del virus de la hepatitis c con antivirales de acci\u00f3n directa en usuarios de drogas por v\u00eda parenteral","name":"articletitle","label":"Article Title"},{"value":"Gastroenterolog\u00eda y Hepatolog\u00eda","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.gastrohep.2021.09.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Espa\u00f1a, S.L.U. All rights reserved.","name":"copyright","label":"Copyright"}]}}